Literature DB >> 6603317

Analysis of thymocyte subpopulations following treatment with sex hormones.

E A Novotny, E S Raveche, S Sharrow, M Ottinger, A D Steinberg.   

Abstract

Sex steroids were found to affect both murine and avian immune systems. Female and male (NZB X NZW)F1 mice were castrated at 2 weeks of age and given Silastic implants containing either dihydrotestosterone or estradiol. Four weeks following treatment, the thymuses were studied for cell cycle kinetics and for the presence of various cell surface antigens using fluorescein-conjugated antisera and flow cytometric techniques. Estradiol therapy resulted in an increase in mature thymocytes, that is, thymocytes that had decreased peanut agglutinin receptors and decreased Thy 1 antigens on their surfaces. Additional studies with anti-Lyt 1 and 2 indicated that these mature thymocytes were of the "helper" rather than the "suppressor" phenotype. Estradiol therapy resulted in an increase in the percentages of proliferating cells in the spleen and a decrease in the percentages of proliferating cells in the thymus. In contrast, in the avian system, estradiol had little effect on proliferation in immunological organs. Dihydrotestosterone was a potent inhibitor of proliferation in the avian bursa. These results indicate that sex hormones have specific effects on different immune cell subpopulations. In the murine system the male is the heterogametic sex but in the avian system the female is the heterogametic sex. Based upon the present and previous studies, we suggest that the primary modulating hormone for immunological sex effects in the mammal is estrogen, whereas in the bird it is androgen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603317     DOI: 10.1016/0090-1229(83)90155-1

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  8 in total

Review 1.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action.

Authors:  S Ansar Ahmed; W J Penhale; N Talal
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

2.  Estradiol is associated with mortality in critically ill trauma and surgical patients.

Authors:  Addison K May; Lesly A Dossett; Patrick R Norris; Erik N Hansen; Randalyn C Dorsett; Kimberley A Popovsky; Robert G Sawyer
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

3.  Association of CYP17 gene polymorphism and rheumatoid arthritis in Chinese patients in central Taiwan.

Authors:  Sui-Foon Lo; Chung-Ming Huang; Hsiu-Chen Lin; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2004-07-03       Impact factor: 2.631

4.  Oestrogen-induced suppression of collagen arthritis; 17 beta-oestradiol is therapeutically active in normal and castrated F1 hybrid mice of both sexes.

Authors:  L Jansson; R Holmdahl
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

5.  Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials.

Authors:  Brian Walitt; Mary Pettinger; Arthur Weinstein; James Katz; James Torner; Mary Chester Wasko; Barbara V Howard
Journal:  Arthritis Rheum       Date:  2008-03-15

6.  Zearalenone, an estrogenic mycotoxin, is an immunotoxic compound.

Authors:  Isis M Hueza; Paulo Cesar F Raspantini; Leonila Ester R Raspantini; Andreia O Latorre; Silvana L Górniak
Journal:  Toxins (Basel)       Date:  2014-03-13       Impact factor: 4.546

Review 7.  Estrogenic bias in T-Lymphocyte biology: Implications for cardiovascular disease.

Authors:  Rachel Rosenzweig; Sahil Gupta; Vinay Kumar; Richard J Gumina; Shyam S Bansal
Journal:  Pharmacol Res       Date:  2021-06-10       Impact factor: 10.334

8.  Suppression of B lymphopoiesis during normal pregnancy.

Authors:  K L Medina; G Smithson; P W Kincade
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.